ArticleJournal for immunotherapy of cancer2025

Inhibition of stromal MAOA leading activation of WNT5A enhance prostate cancer immunotherapy by involving the transition of cancer-associated fibroblasts.

Zhite Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.